KALC 2024 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2024 LOTTE HOTEL WORLD, SEOUL, KOREA
KALC 2024 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2024 LOTTE HOTEL WORLD, SEOUL, KOREA
TIME | ROOM A (Crystal Ballroom 3) |
ROOM B (Crystal Ballroom 2) |
ROOM C (Crystal Ballroom 1) |
---|---|---|---|
08:20-08:30 | Opening | ||
08:30-09:10 | Satellite Symposium I (A) | ||
09:10-09:20 | Break | ||
09:20-10:20 | Session I (A) New generation of immunotherapy | Session I (B) Interventional Pulmonology in Thoracic Malignancy | Session I (C) Low-Dose Computed Tomography Lung Cancer Screening: An Update |
10:20-10:35 | Coffee Break | ||
10:35-11:35 | Session II (A) ADCs in thoracic oncology | Session II (B) Treatment of Lung Cancer in Patients with Severe Respiratory Diseases |
Session II (C) Joint Symposium with HIRA (*KOR) |
11:35-11:50 | Coffee Break | ||
11:50-12:30 | Plenary Session I - Prof. Benjamin Besse (Paris-Saclay University, France) | ||
12:30-13:10 | Luncheon Symposium I | ||
13:10-13:30 | Coffee Break | ||
13:30-14:30 | Session III (A) Update of Thymic tumors | Session III (B) Management of Ultra-Central Lung Tumor | Session III (C) Optimal treatment for elderly patients |
14:30-14:45 | Coffee Break | ||
14:45-15:45 | Session IV (A) Update of EGFR-mutant NSCLC | Session IV (B) Optimal Treatment Approaches and Sequential Strategies for Brain Metastases from NSCLC | Session IV (C) Oral Presentation I |
15:45-16:00 | Coffee Break | ||
16:00-16:40 | Satellite Symposium II (A) | Satellite Symposium II (B) |
TIME | ROOM A (Crystal Ballroom 3) |
ROOM B (Crystal Ballroom 2) |
ROOM C (Crystal Ballroom 1) |
---|---|---|---|
08:20-09:00 | Satellite Symposium III (A) | Satellite Symposium III (B) | Satellite Symposium III (C) |
09:00-09:10 | Break | ||
09:10-10:10 | Session V (A) Small Cell Lung Cancer Recent Update | Session V (B) Updates on Lung Cancer Pathology | Session V (C) Oral Presentation II |
10:10-10:25 | Coffee Break | ||
10:25-11:25 | Session VI (A) Immunotherapy in early-stage NSCLC | Session VI (B) Updates on Emerging Biomarkers and Technologies for Lung Cancer | Session VI (C) Oral Presentation III |
11:25-11:40 | Coffee Break | ||
11:40-12:20 | Luncheon Symposium II | ||
12:20-12:50 | KALC General Meeting | ||
12:50-13:30 | Plenary Session II - Prof. Tony Shu Kam Mok (Chinese University of Hong Kong, Hong Kong SAR, China) | ||
13:30-13:50 | Coffee Break | ||
13:50-14:50 | Session VII (A) Treatment of NSCLC with rare mutations | Session VII (B) Lung cancer surgery after neoadjuvant immunotherapy | Session VII (C) 5 year Anniversary Symposium – National Lung Cancer Screening Program Part 1 (*ENG) |
14:50-15:05 | Coffee Break | ||
15:05-16:05 | Session VIII (A) Incorporating ctDNA assays in clinical practice | Session VIII (B) Surgical options for advanced lung cancer | Session VIII (C) 5 year Anniversary Symposium – National Lung Cancer Screening Program Part 2 (*ENG) |
16:05-16:30 | Closing & Award Ceremony |
24년도 대한폐암학회 연회비를 납부하셔야 회원가로 등록이 가능합니다. 연회비 납부하시겠습니까?
Oral Presentation 1
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0186 | 14:45-14:55 | Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression | Kwon Joong Na | Seoul National University | Korea |
A-0184 | 14:55-15:05 | Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy | Duk Ki Kim | Chungnam National University | Korea |
A-0105 | 15:05-15:15 | Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC) | Jong Yeob Kim | Feinberg School of Medicine, Northwestern University | USA |
A-0127 | 15:15-15:25 | Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract | Joo-Eun Lee | Chungnam National University | Korea |
A-0057 | 15:25-15:35 | Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer | Bo-Guen Kim | Kangbuk Samsung Medical Center | Korea |
A-0042 | 15:35-15:45 | Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity | Cheol-Kyu Park | Chonnam National University | Korea |
Oral Presentation 2
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0226 | 09:10-09:20 | Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study | Junghee Lee | Samsung Medical Center | Korea |
A-0214 | 09:20-09:30 | Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial | Sung Yong Lee | Korea University | Korea |
A-0204 | 09:30-09:40 | What Is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (>5 cm) Non-Small Cell Lung Cancer? | Ye Jin Yoo | Asan Medical Center | Korea |
A-0108 | 09:40-09:50 | Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series | Young Chae | Northwestern University Feinberg School of Medicine | USA |
A-0069 | 09:50-10:00 | Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer | Sangjoon Park | Severance Hospital | Korea |
A-0046 | 10:00-10:10 | Refining patient selection for prophylactic cranial irradiation in limited-stage small-cell lung cancer: Insights from a Korean multi-institutional cohort study | Hye In Lee | Asan Medical Center | Korea |
Oral Presentation 3
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0080 | 10:25-10:35 | Real-world insights: Treatment patterns and overall survival in patients with small-cell lung cancer in South Korea a single center experience | Sehhoon Park | Samsung Medical Center, Sungkyunkwan University School of Medicine | Korea |
A-0196 | 10:35-10:45 | AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients | Kwon Joong Na | Seoul National University | Korea |
A-0167 | 10:45-10:55 | Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients | Jae Ho Cho | Chonnam National University Medical School | Korea |
A-0230 | 10:55-11:05 | Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 | Ji Eun Shin | The Catholic University of Korea St. Vincent's Hospital | Korea |
A-0131 | 11:05-11:15 | Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer | Yang-Gun Suh | National Cancer Center | Korea |
A-0035 | 11:15-11:25 | Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: radiomic prediction | Jihwan Choi | Samsung Medical Center | Korea |
Basic & Translational Research / Biology / Pathology
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0215 | PE1-01 | Engineering precision medicine for lung cancer: Antibody-mimetic scaffolds targeting EGFR | Tushar Kushwaha | All Institute of Medical Sciences | India |
A-0128 | PE1-02 | TP53 mutations in Belarusian patients with non-small cell lung cancer | Hanna Shchayuk | Institute of Genetics and Cytology, National Academy of Sciences of Belarus | Belarus |
A-0109 | PE1-03 | Optimized exosomal miRNA panels for early detection of non-small cell lung cancer | Da Hyun Kang | Chungnam National University | Korea |
A-0060 | PE1-04 | Anticancer effect of Columbianadin against benzopyreneinduced lung cancer in rats: Role of PI3K/Akt/FoxO1 and inflammatory pathway | Vikas Kumar | Sam Higginbottom University of Agriculture, Technology & Sciences | India |
A-0047 | PE1-05 | Role of exosomal proteins in brain-specific metastasis of lung cancer | Dong Ha Kim | Asan Medical Center | Korea |
A-0238 | PE1-06 | The influence of knowledge and attitudes on smoking decisions: Case study of the Pandeyan Boyolai village community, Central Java. | Rinita Istiqomah | Yogyakarta State University | Indonesia |
A-0237 | PE1-07 | Driver genes expression and fusions in patients with lung cancer | Yuliya Stankevich | Institute of Genetics and Cytology of the National Academy of Sciences of Belarus | Belarus |
A-0233 | PE1-08 | Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A meta-analysis | Farhana Sultana Mitu | Islamic University | Bangladesh |
A-0232 | PE1-09 | A meta-analytic approach to find the association between polymorphism with in MicroRNAs and lung cancer risk | Md Abdullah Al Maruf | Islamic University | Bangladesh |
A-0228 | PE1-10 | CTSC regulates cell growth in small cell lung cancer via YAP/PAR2 signaling pathway | Nayoung Kim | Chungnam National University Hospital | Korea |
A-0208 | PE1-11 | Lung Organoid to understand mechanism of therapeutic resistance in lung cancer | Jinwook Choi | School of Life Sciences, Gwangju Institute of Science and Technology (gist) | Korea |
A-0185 | PE1-13 | The impact of Living-Donor Lobar Lung Transplantation (LDLLT) procedure on the sexual function of donors and recipients: A systematic review | Rosinta Hotmaida P Purba | The Pranala Institute | Indonesia |
A-0179 | PE1-14 | Loss of Cereblon (CRBN) enhances lung cancer cell migration and invasion through regulation of cystathionine -synthase (CBS) | Kihun Kim | Gwangju Institute of Science and Technology | Korea |
A-0173 | PE1-15 | Parallel Accumulation-Serial Fragmentation for in-depth proteomic analysis of bronchoalveolar lavage fluid of non-small cell lung cancer | Seung Hyeun Lee | Kyung Hee University Medical Center | Korea |
A-0164 | PE1-16 | Butanolic fraction of Asparagus racemosus root alters the JAK/STAT3 Signaling Pathway to mitigate metastasis, apoptosis, and proliferation in lung cancer | Niti Singh | Marlabs Innovation Pvt Ltd. | India |
A-0161 | PE1-17 | Utilizing machine learning methodologies to forecast the occurence of lung cancer in patients of central region. | Manvendra Singh | Hmfa Miet | India |
A-0160 | PE1-18 | Solid Lipid Nanoparticle of Ganodric acid in the treatment against benzopyreneinduced lung cancer in rats: Nrf2/HO-1 signaling pathway | V Kumar | Shalom Institute of Health & Allied Sciences | India |
A-0156 | PE1-19 | Solid lipid nanoparticles of gallic acid enhances apoptosis and proliferation in rats to lessen lung cancer induced by diethylnitrosamine/2-acetylaminofluorene. | Deepika Singh | Shuats | India |
A-0154 | PE1-20 | The incidence of hematologic paraneoplastic syndromes in newly diagnosed lung cancer patients | Roland Helmizar | Baiturrahmah University | Indonesia |
A-0114 | PE1-22 | A pilot study to discover potential early NSCLC biomarkers in the Filipino secretome | Josemaria Alejandro Corpuz | University of the Philippines-Diliman | Philippines |
A-0090 | PE1-23 | Recapitulation tumor microenvionments with lung cancer organoids for drug screening study | Insu Lee | Seoul National University Bundang Hospital | Korea |
A-0088 | PE1-24 | What is our role to reduce lung cancer mortality rates?: Case studies of 7 countries with the highest lung cancer | Nadia Fazira | Andalas University | Indonesia |
A-0087 | PE1-25 | ARAF p.S214C Mutation Enhances Sorafenib Response in Lung Cancer | Carol Lee | The Chinese University of Hong Kong | Hong Kong |
A-0076 | PE1-27 | Enhancing tumoroid applications with regenix in advanced 3D cell culture models | Da Hye Song | Cellartgen | Korea |
A-0068 | PE1-28 | Regenix in lung cancer PDX models: Advancing research and therapeutic potential | Da Hye Song | Cellartgen | Korea |
A-0063 | PE1-29 | Synergistic anticancer effects of Niclosamide and Osimertinib: Repurposing drugs in autophagy for the treatment of EGFR-mutant lung cancer cells | Yuan-Ming Tsai | Tri-Service General Hospital, National Defense Medical Center | Taiwan |
A-0051 | PE1-30 | Identification of Guanine-quadruplex forming DNA aptamer: A promising therapeutic strategy for EGFR overexpressed non-small cell lung cancer | Deepa Singh | All Institute of Medical Sciences | India |
A-0050 | PE1-31 | Austrian biobanking and biomolecular resources research infrastructure - Important partner for research on biological samples | Luka Brcic | Medical University of Graz | Austria |
A-0049 | PE1-32 | Clinical and genomic features of different KRAS Subtypes in non-small cell lung cancer | Soo Han Kim | Pusan National University Hospital | Korea |
Big Data & AI
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0151 | PE1-34 | Network pharmacology study revealed the multitargets anticancer mechanism of sesamin in NSCLC | Reny Rosalina | University of Palangka Raya | Indonesia |
A-0250 | PE1-35 | Utilizing machine learning algorithms for enhanced lung cancer diagnosis through imaging biomarkers | Divo Helmizar | Stan Jakarta | Indonesia |
A-0239 | PE1-36 | Deep-learning model for personalized recurrence prediction in early-stage non-small cell lung cancer | Daehwan Lee | Spidercore Inc. | Korea |
A-0093 | PE1-38 | Increased risk of lung cancer in individuals with nontuberculous mycobacterial pulmonary disease: A Korean population-based study | Dongwon Park | Hanyang University Medical Center | Korea |
A-0086 | PE1-39 | Deep-learning-driven prediction of lung cancer recurrence using integrated immune profiling and radiomic features from computed tomography scans | Rifaldy Fajar | Yogyakarta State University | Indonesia |
Others
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0064 | PE1-40 | Harnessing computer-aided drug discovery for the development of potent allosteric inhibitors targeting EGFR in NSCLC | Mdaliasif Noor | Chonbuk National University Hospital | Korea |
A-0120 | PE1-42 | The association between prevalence of tobacco use, nitrous oxide emissions and current health expenditure toward lung cancer in asian countries | Devi Yulia Rahmi | Universitas Andalas | Indonesia |
A-0139 | PE1-43 | Self efficacy and quality of life in lung cancer patients: Systematic reviews | Mega Dwi Septivani | Padang State Polytechnic | Indonesia |
A-0166 | PE1-44 | Revealed intermittent fasting benefit: How does the systematic review suggest lung cancer patients should undergo the most effective fasting? | Yesika Simbolon | Atmajaya University | Indonesia |
Pulmonology / Endoscopy
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0067 | PE1-45 | Evaluating the bleeding risk after discontinuation of antiplatelets or anticoagulants in advanced diagnostic bronchoscopy | Bora Lee | The Catholic University of Korea Eunpyeong St. Mary's Hospital | Korea |
Radiology / Staging / Screening / Epidemiology
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0112 | PE1-46 | Factors predicting uptake of counseling visit in a national lung cancer screening program in South Korea | A Ram Kim | University of Ulsan | Korea |
Early / Locally Advanced Non-Small Cell Lung Cancer
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0149 | PE2-01 | Comparison of overall survival between invasive mucinous and non-mucinous lung adenocarcinoma depending on stage and treatment modalities | Youjin Oh | John H. Stroger, Jr. Hospital of Cook County Health | USA |
A-0104 | PE2-02 | Prognostic impact of mucinous vs. non-mucinous lung adenocarcinoma with lepidic growth pattern: a real-world analysis 22,914 patients from SEER | Yujung Heo | Feinberg School of Medicine, Northwestern University | Korea |
A-0134 | PE2-03 | Integrative proteomic and phosphoproteomic: A pilot study on profiling Filipino non-small cell lung cancer patients | Aubrey Mae Lipa | University of the Philippines - Diliman | Philippines |
A-0079 | PE2-04 | Potential and correlation of PET imaging and immune biomarkers for neoadjuvant immunotherapy in stage II/III non-small cell lung cancer | Eun Seong Lee | Korea University Guro Hospital | Korea |
A-0066 | PE2-05 | Discovering potential biomarkers for diagnosis and prognosis of LUAD NSCLC | Baby Rorielyn Dimayacyac-Esleta | University of the Philippines-Diliman | Philippines |
A-0061 | PE2-06 | Whole blood metabolomic patterns in non-small cell lung cancer: A comparative study with healthy controls | Kamal Baswal | Phd Student | India |
Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0126 | PE2-07 | Pediatric mesothelioma: a case report | Heae Surng Park | Ewha Womans University Medical Center | Korea |
A-0125 | PE2-08 | The impact of prevalence of annual freshwater withdrawals, drinking water services and air pollution toward mesothelioma cancer | Ferza Alfath | Alumnus Universitas Andalas | Indonesia |
A-0118 | PE2-09 | Characterization of tumor-infiltrating B cells in malignant pleural mesothelioma and thymic carcinoma using single-cell RNA sequencing and deep learning | Sahnaz Vivinda Putri | International University Semen | Indonesia |
A-0020 | PE2-10 | Well differentiated papillary mesothelial tumor from retrospective diagnosis for 10 years (2013 - 2023) | Nguyen Son Lam | Pham Ngoc Thach Hospital | Vietnam |
Radiotherapy
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0242 | PE2-12 | Clinically significant cardiovascular diseases after postoperative radiotherapy in non-small cell lung cancer: a Korean nationwide cohort study | Byoung Hyuck Kim | Seoul National University Boramae Medical Center | Korea |
A-0209 | PE2-13 | Lung volume reduction as a potential risk factor for symptomatic radiation pneumonitis during concurrent chemoradiotherapy of lung cancer | Yun Hee Lee | The Catholic University of Korea Bucheon St. Mary's Hospital | Korea |
A-0183 | PE2-14 | Radiotherapy for synchronous double primary cancers of lung and prostate: Case report of two patients | Seung Gyu Park | Keimyung University Dongsan Medical Center | Korea |
A-0099 | PE2-15 | Association between antipsychotic drug and survival in patients with lung cancer treated with chemoradiotherapy: A Nationwide Korean Cohort Study | Dong-Yun Kim | Chung-Ang University Hospital | Korea |
A-0071 | PE2-16 | Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: A retrospective comparison with metastasectomy | Youngju Song | Asan Medical Center | Korea |
Surgery
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0155 | PE2-17 | Double lung transplantation in patients with recent history of malignancy | Chan Mi Jung | Feinberg School of Medicine, Northwestern University | USA |
A-0058 | PE2-18 | Feasibility of wedge resection for peripheral clinical T1bN0 or less non-small cell lung cancer | Taeyoung Yun | Seoul National University Hospital | Korea |
A-0092 | PE2-19 | Analysis of the prognostic impact of tumor necrosis in completely resected stage I and II lung adenocarcinoma | Seung Hwan Song | Hanyang University Medical Center | Korea |
Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0133 | PE3-01 | Targeting EGFR and its mutations in peatland fire-induced lung cancer: The therapeutic potential of Kalimantan's endemic plant compounds | Amanda Natania Gracia | Faculty of Mathematics and Natural Sciences, University of Palangka Raya | Indonesia |
A-0082 | PE3-02 | Development of a novel inhibitor against nRAS-mutated lung cancers | Vikas Kumar | Aiims New Delhi | India |
A-0059 | PE3-03 | Health-related quality of life with tepotinib in METex14 skipping NSCLC with brain, liver, adrenal or bone metastases: VISION trial | Beung Chul Ahn | Research Institute and Hospital of National Cancer Center | Korea |
A-0252 | PE3-04 | Unlocking the potential of fasting to optimize chemotherapy outcomes in lung cancer: A bibliometric exploration | Fairuz Tsuraya Ramadhani | Universitas Palangka Raya | Indonesia |
A-0224 | PE3-05 | A study to evaluate the effectiveness of exosomal proteins as biomarkers in non-small cell lung carcinoma | Aashal Bhavesh Shah | Gmers Medical College and Hospital | India |
A-0205 | PE3-06 | Efficacy of Nivolumab in patients with recurrent advanced nonsmall cell lung cancer in Indian population | Jatinkumar Veljibhai Dhanani | Gmers Medical College, Navsari | India |
A-0201 | PE3-07 | Evaluating the efficacy of sequential IL-6 and PD-1 inhibitor treatment in murine lung cancer: Immune modulation and tumor size reduction | Soyun Kim | Chungnam National University Hospital | Korea |
A-0169 | PE3-08 | Delta-He as a novel prognostic biomarker in NSCLC patients treated with PD-1/PD-L1 inhibitors | Green Hong | Chungnam National University Hospital | Korea |
A-0157 | PE3-09 | Bioinformatics identification of potent siRNAs targeting vscular endothelial growth factor receptor and mesenchymal-epithelial transition factor for non-small cell lung cancer | Rian Ka Praja | Universitas Palangka Raya | Indonesia |
A-0122 | PE3-10 | AI-driven predictive model of ALK inhibitor responses merging single-cell RNA sequencing with radiogenomics in advanced non-small cell lung cancer | Prihantini Prihantini | Bandung Institute of Technology | Indonesia |
A-0116 | PE3-11 | Impact of antibiotic exposure on the effectiveness of immune checkpoint inhibitors in patients with non-small cell lung cancer | Myeong Geun Choi | Ewha Womans University Mokdong Hospital | Korea |
A-0089 | PE3-12 | Blood plasma proteomic-based identification and characterization of aberrantly expressed proteins in EGFR TKI resistant late-stage NSCLC patients | Ferdinand Mira | Institute of Chemistry, University of the Philippines, Diliman | Philippines |
A-0065 | PE3-13 | Analysis of clinical characteristics and survival after completion of two years of immune checkpoint inhibitor treatment in advanced NSCLC | Kyoungmin Lee | Korea University Guro Hospital | Korea |
Palliative Care
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0115 | PE3-14 | Digital aging and mental health deteriorationsof among Indonesian elderly with lung cancer: A psychosocioeconomic analysis | Lintong Hottua Simbolon | The Pranala Institute | Indonesia |
A-0256 | PE3-15 | The significance of music-based interventions in lung cancer patients in palliative care : A bibliometric analysis | Mery Enjelica Cristin | Universitas Palangka Raya | Indonesia |
A-0249 | PE3-16 | Music therapy and spiritual nursing care for lung cancer sufferers in Indonesia post surgery | Yusril Yusril | Uin Sjech M. Djamil Djambek Bukittinggi | Indonesia |
A-0241 | PE3-17 | Palliative care for lung cancer patients: Before and during the COVID-19 pandemic | Yusril Yusril | Uin Sjech M. Djamil Djambek Bukittinggi | Indonesia |
A-0213 | PE3-18 | Quality of life among chronic lung disease patients in Indonesia: Insights from the Indonesia family life survey | Derizal Derizal | Ip Trisakti | Indonesia |
A-0207 | PE3-19 | Analysis of health management of mesothelioma patients in Indonesia, including early diagnosis, treatment, and palliative support. | Andi Makkasau Andi Ureng | Alami Gsb | Indonesia |
A-0198 | PE3-20 | Best nudge to influence people's behaviour for better off: Choices architecture on lung cancer prevention? | Helen Try Juniasti | Cendrawasih University | Indonesia |
A-0165 | PE3-21 | Prevention and treatment of lung disease disease: How community-based health care take the important role among 17k islands in Indonesia | Hepri Ardianson Purba | The Pranala Institute | Indonesia |
Small Cell Lung Cancer / Neuroendocrine Tumors
Abstract No. | Poster No. | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0189 | PE3-23 | Innovative neural network models for analyzing platinum-based chemotherapy effects in extensive-stage small cell lung cancer (ES-SCLC) patients | Prihantini Prihantini | Bandung Institute of Technology | Indonesia |
A-0048 | PE3-24 | Can AI based on morphology provide clinically more meaningful classification of lung neuroendocrine tumours-lungNENomics project results | Luka Brcic | Medical University of Graz | Austria |
A-0192 | PE3-25 | Anti-tumor activity and safety of autologous Vax-NK/HCC consolidation therapy following first-line chemoimmunotherapy in patients with extensive-stage small cell lung cancer | In-Jae Oh | Chonnam National University Hwasun Hospital | Korea |
A-0136 | PE3-26 | Targeting exosomal microRNA signatures for early detection and prognosis of chemoresistant small cell lung cancer: a machine learning-driven approach | Elfiany Syafruddin | Bulukumba Muhammadiyah University | Indonesia |